Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 185

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Infiltrative and drug‐resistant slow‐cycling cells support metabolic heterogeneity in glioblastoma

Open access
Hoang‐Minh, Lan B, Siebzehnrubl, Florian A, Yang, Changlin, Suzuki‐Hatano, Silveli, Dajac, Kyle, Loche, Tyler, Andrews, Nicholas, Schmoll Massari, Michael, Patel, Jaimin, Amin, Krisha, Vuong, Alvin, Jimenez‐Pascual, Ana, Kubilis, Paul, Garrett, Timothy J, Moneypenny, Craig, Pacak, Christina A, Huang, Jianping, Sayour, Elias J, Mitchell, Duane A, Sarkisian, Matthew R, Reynolds, Brent A, Deleyrolle, Loic P · 2018 · The EMBO Journal

Abstract

Metabolic reprogramming has been described in rapidly growing tumors, which are thought to mostly contain fast‐cycling cells (FCCs) that have impaired mitochondrial function and rely on aerobic glycolysis. Here, we characterize the metabolic landscape of glioblastoma (GBM) and explore metabolic specificities as targetable vulnerabilities. Our studies highlight the metabolic heterogeneity in GBM, in which FCCs harness aerobic glycolysis, and slow‐cycling cells (SCCs) preferentially utilize mitochondrial oxidative phosphorylation for their functions. SCCs display enhanced invasion and chemoresistance, suggesting their important role in tumor recurrence. SCCs also demonstrate increased lipid contents that are specifically metabolized under glucose‐deprived conditions. Fatty acid transport in SCCs is targetable by pharmacological inhibition or genomic deletion of FABP7, both of which sensitize SCCs to metabolic stress. Furthermore, FABP7 inhibition, whether alone or in combination with glycolysis inhibition, leads to overall increased survival. Our studies reveal the existence of GBM cell subpopulations with distinct metabolic requirements and suggest that FABP7 is central to lipid metabolism in SCCs and that targeting FABP7‐related metabolic pathways is a viable therapeutic strategy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.201798772

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 185

Metadata

Authors
Hoang‐Minh, L. B., Siebzehnrubl, F. A., Yang, C., Suzuki‐Hatano, S., Dajac, K., Loche, T., Andrews, N., Schmoll Massari, M., Patel, J., Amin, K., Vuong, A., Jimenez‐Pascual, A., Kubilis, P., Garrett, T. J., Moneypenny, C., Pacak, C. A., Huang, J., Sayour, E. J., Mitchell, D. A., Sarkisian, M. R., Reynolds, B. A., & Deleyrolle, L. P.
Venue
The EMBO Journal
Published
2018-10-15
Volume
37
Issue
23
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2897563882
Cited by
185
References
17
FWCI
4.61
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Infiltrative and drug‐resistant slow‐cycling cells support metabolic heterogeneity in glioblastoma. https://app.cochat.ai/papers/10.15252/embj.201798772
The paper
Hoang‐Minh, L. B., Siebzehnrubl, F. A., Yang, C., Suzuki‐Hatano, S., Dajac, K., Loche, T., Andrews, N., Schmoll Massari, M., Patel, J., Amin, K., Vuong, A., Jimenez‐Pascual, A., Kubilis, P., Garrett, T. J., Moneypenny, C., Pacak, C. A., Huang, J., Sayour, E. J., Mitchell, D. A., . . . Deleyrolle, L. P. (2018). Infiltrative and drug‐resistant slow‐cycling cells support metabolic heterogeneity in glioblastoma. The EMBO Journal. https://doi.org/10.15252/embj.201798772

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.